In this report, we also observed that H89 not only induces the recruitment of CD8+ and CD4+ T cells at the tumor site but also allows their activation, attested by, e.g., the proinflammatory cytokine IFN-γ induction, emphasizing the establishment of immune protection against tumor development. The gene discussed is CD8A; the disease is neoplasm.